Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEV3A and FP9-MVA ME-TRAP Malaria Vaccine Challenge
NCT00408668Phase 2Completed
- Sponsor
- University of Oxford
- Start
- Aug 2005
- Modality
- Viral Vector Vaccines, Peptides, DNA Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of PEV3A, FP9 ME-TRAP, MVA ME-TRAP in malaria, sponsored by University of Oxford. Started Aug 2005; status: completed.
02
Drugs
PEV3AFP9 ME-TRAPMVA ME-TRAP
03
Conditions
malaria
Beyond the preview
Go deeper on NCT00408668.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00408668.